LIDOCAINE – THE GOLD STANDARD ANAESTHETIC? WHY NOT ARTICAINE?

01-12-2021

In dentistry, the most effective medicines for the prevention and management of pain are local anaesthetics. While the world is more than familiar with lidocaine as an anaesthetic, articaine has quickly emerged as an alternative to the gold-standard. Although its use varies by world region, articaine is now favoured for several dental procedures. The secret lies in its unique structure and pharmacology, which have inspired key opinion leaders on anaesthesia to advocate for its use over lidocaine.
Inibsa

LIDOCAINE AS THE GOLD STANDARD 

Lidocaine was developed in 1943 as the first amide anaesthetic. Due to the plethora of data consistently collected showing an exemplary safety profile, lidocaine has been the standard anaesthetic for over half a century. In fact, one of the latest comprehensive studies found that lidocaine is still one of the safest local anaesthetics [1]. In fact, the FDA has classified it as one of the safest local anaesthetics (category B) for pregnant women citing no teratogenic effects [2, 3].

EMERGENCE OF ARTICAINE

Articaine was synthesized in 1969 and was originally called “carticaine” [4]. Less than a decade later it was put into clinical practice in Germany. To this day, it is the only anaesthetic that has been specifically designed for dentistry! Most of Europe has quickly adopted a preference of articaine over lidocaine. Canada, the UK, and other regions have recently followed suit. Worldwide, it is the second most popular local anaesthetic with lidocaine still being number one. It is on track to soon become the most popular. 

A recent study looking at the adverse effects produced by local anaesthetics concluded that articaine has the similar adverse event profile as lidocaine in dental procedures [5]. If both are safe, why is articaine gaining momentum over lidocaine? An increasing body of literature points to articaine as the more efficacious local anaesthetic when compared to lidocaine in dental procedures.

PHYSICAL AND CHEMICAL PROPERTIES: THE SUPERIOR PHARMACOLOGY OF ARTICAINE

The unique structure of articaine increases its ability to permeate tissue membranes (liposolubility) and makes it four times more potent than lidocaine [6]. Additionally, when compared with lidocaine, the onset of anaesthesia can be slightly faster with articaine, and its duration tends to be longer [7].

Like lidocaine, Aaticaine is an amide local anaesthetic [7]. However, it possesses a thiophene ring in its structure that allows it to be more lipid soluble than lidocaine, making it easier to permeate soft and hard tissue than other anaesthetics. It also has a unique ester group that allows 90-95 percent of it to get metabolised in the blood plasma instead of the liver. Esterases in the blood hydrolyse it quickly after injection.

Due to this quick metabolism, the elimination half-life of articaine is also uniquely short when compared to lidocaine [7]. It is 27-29 minutes in adults, 27 minutes in geriatric patients, and 18-23 minutes in paediatric patients. This is of particular importance given the higher propensity for paediatric patients to experience an overdose from local anaesthetics due to their lower weight profile. This leaves children more vulnerable to seizure, unconsciousness, apnoea, hypoxia, low blood pressure, and bradycardia [8]. 

TACKLING THE SHORTCOMINGS OF LIDOCAINE WITH ARTICAINE


Due to its greater ability to permeate tissue, articaine has a wider breadth of applications in dentistry when compared to lidocaine.

Achieving anaesthetic effect by local infiltration of lidocaine in mandibular teeth is quite the challenge. The thickness of the mandible bone makes it difficult to infiltrate for most amide local anaesthetics, like lidocaine [9]. However, the unique structure of articaine grants it superior permeability into bone and tissue; therefore, articaine has higher maxillary infiltration than lidocaine [9]. In fact, it is well established that buccal infiltration with articaine increases the effectiveness of lidocaine-inferior alveolar nerve block (IANB) [10]. This is especially true in patients with symptomatic irreversible pulpitis where achieving an anaesthetic effect is difficult due to the acidified environment of the inflamed tissue [11].

Overall, the superior lipid solubility, shorter half-life and relatively faster onset time and longer duration position articaine to take over the local anaesthetic market and most probably move, sometime in the future, into lidocaine’s number one position worldwide.

REFERENCES:
1. https://pubmed.ncbi.nlm.nih.gov/32473767/
2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021381s006lbl.pdf
3. https://www.dentalcare.com/en-us/professional-education/ce-courses/ce325/local-anesthesia-and-pregnancy
4. https://www.jpsr.pharmainfo.in/Documents/Volumes/vol7Issue09/jpsr07091542.pdf
5. https://www.nature.com/articles/s41405-021-00082-5
6. https://www.nature.com/articles/s41415-021-2941-z
7. https://www.sciencedirect.com/science/article/abs/pii/S0099239915005014
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149003/pdf/anesthprog00228-0005.pdf
9. khttps://www.sciencedirect.com/science/article/abs/pii/S1532338217300763
10. https://pubmed.ncbi.nlm.nih.gov/30174101/
11. https://www.sciencedirect.com/science/article/abs/pii/S0099239915006007
12. https://www.sciencedirect.com/science/article/pii/S0020653920365175